| Molecular diagnostic of solid tumor using a next generation sequencing custom-designed multi-gene panel D de Biase, G Acquaviva, M Visani, V Sanza, CM Argento, A De Leo, ... Diagnostics 10 (4), 250, 2020 | 57 | 2020 |
| Molecular alterations in pancreatic tumors M Visani, G Acquaviva, A De Leo, V Sanza, L Merlo, T Maloberti, ... World journal of gastroenterology 27 (21), 2710, 2021 | 24 | 2021 |
| Association of the genomic profile of medullary thyroid carcinoma with tumor characteristics and clinical outcomes in an international multicenter study B Xu, K Viswanathan, MS Ahadi, S Ahmadi, B Alzumaili, MA Bani, ... Thyroid 34 (2), 167-176, 2024 | 14 | 2024 |
| Next-generation sequencing panel for 1p/19q codeletion and IDH1-IDH2 mutational analysis uncovers mistaken overdiagnoses of 1p/19q codeletion by FISH D de Biase, G Acquaviva, M Visani, G Marucci, A De Leo, T Maloberti, ... The Journal of Molecular Diagnostics 23 (9), 1185-1194, 2021 | 13 | 2021 |
| Integrated clinicopathologic and molecular analysis of endometrial carcinoma: Prognostic impact of the new ESGO-ESTRO-ESP endometrial cancer risk classification and proposal of … D de Biase, T Maloberti, AG Corradini, F Rosini, M Grillini, M Ruscelli, ... Frontiers in Medicine 10, 1146499, 2023 | 12 | 2023 |
| Molecular characterization of pancreatic ductal adenocarcinoma using a next-generation sequencing custom-designed multigene panel D Malvi, F Vasuri, T Maloberti, V Sanza, A De Leo, A Fornelli, M Masetti, ... Diagnostics 12 (5), 1058, 2022 | 11 | 2022 |
| Relevance of ARID1A Mutations in Endometrial Carcinomas A De Leo, G Ravegnini, F Musiani, T Maloberti, M Visani, V Sanza, ... Diagnostics 12 (3), 592, 2022 | 10 | 2022 |
| Prognostic impact of pathologic features in molecular subgroups of endometrial carcinoma M Ruscelli, T Maloberti, AG Corradini, F Rosini, G Querzoli, M Grillini, ... Journal of Personalized Medicine 13 (5), 723, 2023 | 7 | 2023 |
| Clinical relevance of gene mutations and rearrangements in advanced differentiated thyroid cancer M Nannini, A Repaci, MC Nigro, A Colapinto, V Vicennati, T Maloberti, ... ESMO open 8 (6), 102039, 2023 | 6 | 2023 |
| Correlation of molecular alterations with pathological features in hepatocellular carcinoma: Literature review and experience of an Italian center T Maloberti, A De Leo, V Sanza, E Gruppioni, A Altimari, M Riefolo, ... World Journal of Gastroenterology 28 (25), 2854, 2022 | 6 | 2022 |
| Evaluation of an institutional series of low-grade oncocytic tumor (LOT) of the kidney and review of the mutational landscape of LOT C Ricci, F Ambrosi, T Franceschini, F Giunchi, A Grillini, E Franchini, ... Virchows Archiv 483 (5), 687-698, 2023 | 5 | 2023 |
| Expanding the Spectrum of BRAF Non-V600E Mutations in Thyroid Nodules: Evidence-Based Data from a Tertiary Referral Centre A De Leo, D Serban, T Maloberti, V Sanza, S Coluccelli, A Altimari, ... International Journal of Molecular Sciences 24 (4), 4057, 2023 | 5 | 2023 |
| A hypothesis-generating analysis on the role of TERT promoter mutation in advanced urothelial carcinoma treated with immunotherapy. PV Marchese, V Mollica, D De Biase, F Giunchi, E Tassinari, A Marchetti, ... Pathology-Research and Practice 236, 153983, 2022 | 5 | 2022 |
| Multi-gene custom panels for the characterisation of metastatic colorectal carcinoma in clinical practice: express the role of PIK3CA mutations D de Biase, U Malapelle, A De Leo, T Maloberti, M Visani, P Pisapia, ... Journal of Clinical Pathology 75 (7), 488-492, 2022 | 4 | 2022 |
| Multi-Gene Next-Generation Sequencing Panel for Analysis of BRCA1/BRCA2 and Homologous Recombination Repair Genes Alterations Metastatic Castration … T Maloberti, A De Leo, S Coluccelli, V Sanza, E Gruppioni, A Altimari, ... International Journal of Molecular Sciences 24 (10), 8940, 2023 | 3 | 2023 |
| BRAF and MLH1 Analysis Algorithm for the Evaluation of Lynch Syndrome Risk in Colorectal Carcinoma Patients: Evidence-Based Data from the Analysis of 100 … T Maloberti, A De Leo, V Sanza, L Merlo, M Visani, G Acquaviva, ... Journal of Molecular Pathology 3 (3), 115-124, 2022 | 3 | 2022 |
| KIT/PDGFRA Variant Allele Frequency as Prognostic Factor in Gastrointestinal Stromal Tumors (GISTs): Results From a Multi-Institutional Cohort Study L Incorvaia, D De Biase, M Nannini, E Fumagalli, B Vincenzi, I De Luca, ... The Oncologist 29 (1), e141-e151, 2024 | 2 | 2024 |
| Case report: Dramatic response to pralsetinib in an elderly patient with advanced RET-fusion positive papillary thyroid carcinoma M Nannini, A Repaci, G Ricco, M Ianni, A Golemi, V Maiolo, M Ferrari, ... Frontiers in Oncology 12, 1042525, 2022 | 2 | 2022 |
| Multifocal fibrosing thyroiditis: an under-recognized mimicker of papillary thyroid carcinoma A Orsatti, A De Leo, F Chiarucci, G Simoncini, N Cremonini, A Fornelli, ... Endocrine Pathology 33 (3), 335-345, 2022 | 2 | 2022 |
| Next-generation technologies in predictive molecular pathology of lung cancers D de Biase, T Maloberti, A De Leo, V Sanza, M Visani, E Gruppioni, ... Journal of Xiangya Medicine 7, 1-13, 2022 | 2 | 2022 |
